trial · primary record
Zanidatamab
Non Small Cell Lung Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2030-12-07 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07899801 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:58.562Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07899801
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zanidatamab · compound